HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice.

Afficher d'autres versions (1)

This study investigated the effects of 2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido) acetic acid (IOX3), a selective small molecule inhibitor of hypoxia-inducible factor (HIF) prolyl hydroxylases, on mouse brains subject to transient focal cerebral ischaemia. Male, 8- to 12-week-old C57/B6 mice w...

Description complète

Détails bibliographiques
Auteurs principaux:	Chen, R, Ogunshola, O, Yeoh, K, Jani, A, Papadakis, M, Nagel, S, Schofield, C, Buchan, A
Format:	Journal article
Langue:	English
Publié:	2014

Documents similaires

HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice
par: Chen, R, et autres
Publié: (2014)

Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice.
par: Chen, R, et autres
Publié: (2012)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
par: Maria Savyuk, et autres
Publié: (2020-07-01)

Regulation of HIF: prolyl hydroxylases.
par: Stolze, I, et autres
Publié: (2006)

Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model
par: Singh, A, et autres
Publié: (2020)

Cerebral blood flow alteration in neuroprotection following cerebral ischaemia.
par: Sutherland, B, et autres
Publié: (2011)

Cerebral blood flow alteration in neuroprotection following cerebral ischaemia
par: Sutherland, B, et autres
Publié: (2011)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
par: Mole, D, et autres
Publié: (2003)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
par: McNeill, L, et autres
Publié: (2002)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
par: Schlemminger, I, et autres
Publié: (2003)

Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats.
par: Nagel, S, et autres
Publié: (2011)

Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats
par: Nagel, S, et autres
Publié: (2011)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
par: Flashman, E, et autres
Publié: (2010)

Therapeutic manipulation of the HIF hydroxylases.
par: Nagel, S, et autres
Publié: (2010)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
par: Cockman, M, et autres
Publié: (2019)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
par: Matthew E Cockman, et autres
Publié: (2019-09-01)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
par: Tuckerman, JR, et autres
Publié: (2004)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
par: Chan, M, et autres
Publié: (2016)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
par: Chowdhury, R, et autres
Publié: (2013)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
par: Chowdhury, R, et autres
Publié: (2016)

Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2
par: Richardson, NL, et autres
Publié: (2021)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
par: Rasheduzzaman Chowdhury, et autres
Publié: (2016-08-01)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
par: Yeh, TL, et autres
Publié: (2017)

Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
par: Moritz J. Strowitzki, et autres
Publié: (2021-04-01)

Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
par: Yeoh, K, et autres
Publié: (2013)

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes
par: Wijeyekoon, JB
Publié: (2013)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
par: Andrey A. Poloznikov, et autres
Publié: (2021-01-01)

USE OF PROLYL HYDROXYLASE INHIBITORS TO INDUCE HIF-RELATED METABOLIC CHANGES AND INCREASE C-KIT EXPRESSION IN CARDIOSPHERE-DERIVED CELLS
par: Tan, S, et autres
Publié: (2011)

Inhibition of a viral prolyl hydroxylase
par: Langley, G, et autres
Publié: (2019)

Mutation Analysis of HIF-prolyl hydroxylases (PHD/EGLN) in Inherited Phaeochromocytoma and Renal Cell Carcinoma
par: Astuti, D, et autres
Publié: (2010)

Suppression of the inflammatory response by diphenyleneiodonium after transient focal cerebral ischemia.
par: Nagel, S, et autres
Publié: (2012)

Relative Contribution of Prolyl Hydroxylase-Dependent and -Independent Degradation of HIF-1alpha by Proteasomal Pathways in Cerebral Ischemia
par: Yomna Badawi, et autres
Publié: (2017-05-01)

A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging
par: Mayer, M, et autres
Publié: (2018)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
par: Holt-Martyn, JP, et autres
Publié: (2019)

Structural, biochemical and inhibition studies on hypoxia-inducible factor (HIF) prolyl hydroxylases
par: Lippl, K
Publié: (2018)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
par: Masson, N, et autres
Publié: (2003)

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
par: Takahiro Kambara, et autres
Publié: (2024-03-01)

HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
par: Kiichi Hirota
Publié: (2021-04-01)

The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer
par: Kilian B. Kennel, et autres
Publié: (2022-11-01)

Network activity in primary hippocampal cultures upon HIF-prolyl hydroxylase inhibition
par: Savyuk, Maria Olegovna, et autres
Publié: (2021-05-01)